Are you Dr. Crapanzano?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
630 W 168th St
Ph 1564W
New York, NY 10032Phone+1 212-305-7399Fax+1 212-746-3856
Summary
- Dr. John Crapanzano, MD is a board certified pathologist in New York, New York. He is currently licensed to practice medicine in New York, Connecticut, and Texas. He is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center and New York-Presbyterian Hospital.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Cytopathology, 1999 - 2000
- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1998 - 1999
- Louisiana State University School of MedicineResidency, Pathology-Anatomic and Clinical, 1992 - 1997
- Louisiana State University School of Medicine in New OrleansClass of 1992
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- NY State Medical License 1998 - 2026
- TX State Medical License 2008 - 2026
- CT State Medical License 2010 - 2025
- LA State Medical License 1993 - 2025
- TN State Medical License 1997 - 2000
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Case of lung fine needle aspiration showing mucinous cells and extracellular mucin.Maelle Saliba, Marie C Smithgall, Anjali Saqi, John P Crapanzano, Simon Sung
Diagnostic Cytopathology. 2024-10-01 - 4 citationsEndotracheal nebulization of gold nanoparticles for noninvasive pulmonary drug delivery.Andreacarola Urso, Federica Meloni, Manuela Malatesta, Rocco Latorre, Christopher Damoci
Nanomedicine. 2023-02-01 - 1 citationsALK Gene Rearrangements in Lung Adenocarcinomas: Concordance of Immunohistochemistry, Fluorescence In Situ Hybridization, RNA In Situ Hybridization, and RNA Next-Gener...Carleigh R. Canterbury, Helen Fernandes, John P. Crapanzano, Vundavalli V. Murty, Mahesh M. Mansukhani
JTO Clinical and Research Reports. 2021-09-25